1. Inici
  2. Publicacions
  3. Hnf4 alpha is a key gene that can generate columnar metaplasia in oesophageal epithelium

Hnf4 alpha is a key gene that can generate columnar metaplasia in oesophageal epithelium

Data de publicació:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Colleypriest, Benjamin J.
  • Burke, Zoe D.
  • Griffiths, Leonard P.
  • Chen, Yu
  • Yu, Wei-Yuan
  • Bock, Michael
  • Biddlestone, Leigh
  • Quinlan, Jonathan M.
  • Ward, Stephen G.
  • Farrant, J. Mark
  • Slack, Jonathan M. W.
  • Tosh, David

Grups d'Investigació

Abstract

Barrett's metaplasia is the only known morphological precursor to oesophageal adenocarcinoma and is characterized by replacement of stratified squamous epithelium by columnar epithelium. The cell of origin is uncertain and the molecular mechanisms responsible for the change in cellular phenotype are poorly understood. We therefore explored the role of two transcription factors, Cdx2 and HNF4 alpha in the conversion using primary organ cultures. Biopsy samples from cases of human Barrett's metaplasia were analysed for the presence of CDX2 and HNF4 alpha. A new organ culture system for adult murine oesophagus is described. Using this, Cdx2 and HNF4 alpha were ectopically expressed by adenoviral infection. The phenotype following infection was determined by a combination of PCR, immunohistochemical and morphological analyses. We demonstrate the expression of CDX2 and HNF4 alpha in human biopsy samples. Our oesophageal organ culture system expressed markers characteristic of the normal SSQE: p63, K14, K4 and loricrin. Ectopic expression of HNF4 alpha, but not of Cdx2 induced expression of Tff3, villin, K8 and E-cadherin. HNF4 alpha is sufficient to induce a columnar-like phenotype in adult mouse oesophageal epithelium and is present in the human condition. These data suggest that induction of HNF4 alpha is a key early step in the formation of Barrett's metaplasia and are consistent with an origin of Barrett's metaplasia from the oesophageal epithelium.

Dades de la publicació

ISSN/ISSNe:
0301-4681, 1432-0436

Differentiation  ELSEVIER SCI LTD

Tipus:
Article
Pàgines:
39-49
PubMed:
27875772
Factor d'Impacte:
1,259 SCImago ℠
Quartil:
Q2 SCImago ℠

Cites Rebudes en Web of Science: 18

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Keywords

  • Barrett's oesophagus; HNF4 alpha; Hepatocyte nuclear factor 4-alpha; Oesophageal cancer; Metaplasia

Projectes associats

DESARROLLO DE UN MODELO HEPATOCELULAR HUMANO DIFERENCIADO PARA ESTUDIOS DE METABOLISMO Y POTENCIAL INDUCTOR DE NUEVOS FARMACOS

Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL

SAF2003-09353 . 2003

DEVELOPMENT OF A HIGH THROUGHPUT GENOMICS-BASED TEST FOR ASSESSING GENOTOXIC AND CARCINOGENIC PROPERTIES OF CHEMICAL COMPOUNDS IN VITRO

Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL

CARCINOGENOMICS . COMISION EUROPEA . 2006

LINTOP

Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL

LSHB-CT-2006-037499 - LINTOP . FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2005

MECANISMOS TRNACRIPCIONALES IMPLICADOS EN LA ETIOLOGIA DEL HIGADO GRASO NO ALCOHOLICO. ESTUDIOS EN UN MODELO CELULAR HUMANO DE ESTEATOSIS Y APLICACION AL TRANSPLANTE DE HEPATOCITOS EN TERAPIA CELULAR.

Investigador Principal: RAMIRO JOVER ATIENZA

PI07/0550 . INSTITUTO DE SALUD CARLOS III . 2007

MECANISMOS TRANSCRIPCIONALES IMPLICADOS EN EL HIGADO GRASO NO ALCOHOLICO DE ORIGEN METABOLICO E IATROGENICO: INFLUENCIA DE LA RESISTENCIA A LA INSULINA

Investigador Principal: RAMIRO JOVER ATIENZA

PI10/00194 . INSTITUTO DE SALUD CARLOS III . 2010

ESTEATOSIS HEPÁTICA POR MEDICAMENTOS: NUEVOS MECANISMOS Y BIOMARCADORES APLICABLES AL DESARROLLO FARMACÉUTICO Y A UNA TERAPIA MÁS RACIONAL EN PACIENTES CON SÍNDROME METABÓLICO.

Investigador Principal: RAMIRO JOVER ATIENZA

PI13/01470 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014

Compartir la publicació